Evidence map›Paper›PMID 25831155›Full record

ArticleScientific reports2015

A cost-effective RNA sequencing protocol for large-scale gene expression studies.

Zhonggang Hou, Peng Jiang, Scott A Swanson, Angela L Elwell, Bao Kim S Nguyen, Jennifer M Bolin, Ron Stewart, James A Thomson

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Enhancer Reprogramming Reveals the Tumorigenic Role of PTPRZ1 in Lung Squamous Cell Carcinoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. The role of mitochondria in sex- and age-specific gene expression in a species without sex chromosomes.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhonggang HouMorgridge Institute for Research, Madison, Wisconsin, United States of America.
Peng JiangMorgridge Institute for Research, Madison, Wisconsin, United States of America.
Scott A SwansonMorgridge Institute for Research, Madison, Wisconsin, United States of America.
Angela L ElwellMorgridge Institute for Research, Madison, Wisconsin, United States of America.
Bao Kim S NguyenMorgridge Institute for Research, Madison, Wisconsin, United States of America.
Jennifer M BolinMorgridge Institute for Research, Madison, Wisconsin, United States of America.
Ron StewartMorgridge Institute for Research, Madison, Wisconsin, United States of America.
James A Thomson1] Morgridge Institute for Research, Madison, Wisconsin, United States of America [2] Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America [3] Department of Molecular, Cellular, and Developmental Biology, University of California Santa Barbara, Santa Barbara, California, United States of America.

Funding

Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and TeratogenicityUH2TR000506 · NCATS · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · PI THOMSON, JAMES ALEXANDER · 2012 to 2013
$2.4M
NCATS NIH HHS 1UH2TR000506-01NCATS NIH HHS UH2 TR000506
6 · The paper itself

Abstract

RNA sequencing has increasingly become an indispensable tool for biological research. While sequencing costs have fallen dramatically in recent years, the current cost of RNA sequencing, nonetheless, remains a barrier to even more widespread adoption. Here, we present a simple RNA sequencing protocol with substantially reduced costs. This protocol uses as little as 10 ng of total RNA, allows multiplex sequencing of up to 96 samples per lane, and is strand specific. Extensive validation using human embryonic stem cells showed high consistency between technical replicates at various multiplexing levels.

Indexed as

Gene ExpressionCost-Benefit AnalysisGene Expression ProfilingGene LibraryHigh-Throughput Nucleotide SequencingHumansReproducibility of ResultsSequence Analysis, RNA

Identifiers

PMID25831155
PMCPMC4381617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.